Here’s whether Healthpeak Properties, Inc. (DOC) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Neutral.
🔵
Neutral
Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+1.54% over 10 days); strong 1-year return of +22.0%; 3-month momentum positive (+7.4%). Concerns: below the 50-day MA (medium-term momentum negative); RSI 28 — oversold. Currently 9.4% off its 52-week high. Score: +3/7.
DOC is holding above its long-term 200-day MA ($18.36) but has slipped below the 50-day MA ($21.30), pointing to short-term weakness in an otherwise intact trend. An RSI of 27.8 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of +22.0% compares to +20.4% for SPY (beat the market by 1.6%).
$10,000 invested 1 year ago→ $12,201 today
vs. S&P 500 (SPY) — same period beat market by 1.6%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($18.36)
✗Above 50-day MA ($21.30)
!RSI(14) neutral zone (30–70) — currently 27.8
✓Positive return (+22.0%)
✓Within 10% of period high (−9.4%)
Period Range $20.79
$15.70$22.95
RSI (14) 27.8
0 · OversoldOverbought · 100
Key Metrics
Price$20.79
Period Return+22.0%
Period High$22.95
Period Low$15.70
Drawdown−9.4%
MA-50$21.30
MA-200$18.36
RSI (14)27.8
Avg Volume (30d)5.9M
vs. SPYbeat by 1.6%
Return Rank#452 of 1252
Trend Signals
Price is above the 200-day moving average ($18.36)